SARS-CoV-2 infection in children and adolescents increases risk for cardiovascular disease, compared with uninfected individuals.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.